Matches in SemOpenAlex for { <https://semopenalex.org/work/W2965854857> ?p ?o ?g. }
- W2965854857 endingPage "e0220345" @default.
- W2965854857 startingPage "e0220345" @default.
- W2965854857 abstract "Two manufacturers, Maxim Biomedical and Sedia Biosciences Corporation, supply CDC-approved versions of the HIV-1 Limiting Antigen Avidity EIA (LAg) for detecting 'recent' HIV infection in cross-sectional incidence estimation. This study assesses and compares the performance of the two assays for incidence surveillance.We ran both assays on a panel of 2,500 well-characterized HIV-1-infected specimens. We analysed concordance of assay results, assessed reproducibility using repeat testing and estimated mean durations of recent infection (MDRIs) and false-recent rates (FRRs) for a range of normalized optical density (ODn) thresholds, alone and in combination with viral load thresholds. We defined three hypothetical surveillance scenarios, similar to the Kenyan and South African epidemics, and a concentrated epidemic. These scenarios allowed us to evaluate the precision of incidence estimates obtained by means of various recent infection testing algorithms (RITAs) based on each of the two assays.The Maxim assay produced lower ODn values than the Sedia assay on average, largely as a result of higher calibrator readings (mean OD of 0.749 vs. 0.643), with correlation of normalized readings lower (R2 = 0.908 vs. R2 = 0.938). Reproducibility on blinded control specimens was slightly better for Maxim. The MDRI of a Maxim-based algorithm at the 'standard' threshold (ODn ≤1.5 & VL >1,000) was 201 days (95% CI: 180,223) and for Sedia 171 (152,191). The difference Differences in MDRI were estimated at 32.7 (22.9,42.8) and 30.9 days (21.7,40.7) for the two algorithms, respectively. Commensurately, the Maxim algorithm had a higher FRR in treatment-naive subjects (1.7% vs. 1.1%). The two assays produced similar precision of incidence estimates in the three surveillance scenarios.Differences between the assays can be primarily attributed to the calibrators supplied by the manufacturers. Performance for surveillance was extremely similar, although different thresholds were optimal (i.e. produced the lowest variance of incidence estimates) and at any given ODn threshold, different estimates of MDRI and FRR were obtained. The two assays cannot be treated as interchangeable: assay and algorithm-specific performance characteristic estimates must be used for survey planning and incidence estimation." @default.
- W2965854857 created "2019-08-13" @default.
- W2965854857 creator A5029565900 @default.
- W2965854857 creator A5029812470 @default.
- W2965854857 creator A5044091762 @default.
- W2965854857 creator A5047738652 @default.
- W2965854857 creator A5059924108 @default.
- W2965854857 creator A5062975649 @default.
- W2965854857 creator A5065733906 @default.
- W2965854857 creator A5076665339 @default.
- W2965854857 creator A5077525618 @default.
- W2965854857 creator A5084558976 @default.
- W2965854857 creator A5088720312 @default.
- W2965854857 creator A5088941752 @default.
- W2965854857 date "2019-07-26" @default.
- W2965854857 modified "2023-10-14" @default.
- W2965854857 title "Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for HIV incidence surveillance" @default.
- W2965854857 cites W1148091386 @default.
- W2965854857 cites W1847871882 @default.
- W2965854857 cites W1976831613 @default.
- W2965854857 cites W2050651444 @default.
- W2965854857 cites W2070197170 @default.
- W2965854857 cites W2072887319 @default.
- W2965854857 cites W2085772210 @default.
- W2965854857 cites W2102608095 @default.
- W2965854857 cites W2147958482 @default.
- W2965854857 cites W2326200534 @default.
- W2965854857 cites W2484921702 @default.
- W2965854857 cites W2513888058 @default.
- W2965854857 cites W2562957734 @default.
- W2965854857 cites W2589404076 @default.
- W2965854857 cites W2622909076 @default.
- W2965854857 cites W2755255810 @default.
- W2965854857 cites W2951989761 @default.
- W2965854857 cites W2982285551 @default.
- W2965854857 cites W3104660140 @default.
- W2965854857 doi "https://doi.org/10.1371/journal.pone.0220345" @default.
- W2965854857 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6660077" @default.
- W2965854857 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31348809" @default.
- W2965854857 hasPublicationYear "2019" @default.
- W2965854857 type Work @default.
- W2965854857 sameAs 2965854857 @default.
- W2965854857 citedByCount "16" @default.
- W2965854857 countsByYear W29658548572019 @default.
- W2965854857 countsByYear W29658548572020 @default.
- W2965854857 countsByYear W29658548572021 @default.
- W2965854857 countsByYear W29658548572022 @default.
- W2965854857 countsByYear W29658548572023 @default.
- W2965854857 crossrefType "journal-article" @default.
- W2965854857 hasAuthorship W2965854857A5029565900 @default.
- W2965854857 hasAuthorship W2965854857A5029812470 @default.
- W2965854857 hasAuthorship W2965854857A5044091762 @default.
- W2965854857 hasAuthorship W2965854857A5047738652 @default.
- W2965854857 hasAuthorship W2965854857A5059924108 @default.
- W2965854857 hasAuthorship W2965854857A5062975649 @default.
- W2965854857 hasAuthorship W2965854857A5065733906 @default.
- W2965854857 hasAuthorship W2965854857A5076665339 @default.
- W2965854857 hasAuthorship W2965854857A5077525618 @default.
- W2965854857 hasAuthorship W2965854857A5084558976 @default.
- W2965854857 hasAuthorship W2965854857A5088720312 @default.
- W2965854857 hasAuthorship W2965854857A5088941752 @default.
- W2965854857 hasBestOaLocation W29658548571 @default.
- W2965854857 hasConcept C105795698 @default.
- W2965854857 hasConcept C126322002 @default.
- W2965854857 hasConcept C147483822 @default.
- W2965854857 hasConcept C159047783 @default.
- W2965854857 hasConcept C160798450 @default.
- W2965854857 hasConcept C179223381 @default.
- W2965854857 hasConcept C203014093 @default.
- W2965854857 hasConcept C2524010 @default.
- W2965854857 hasConcept C33923547 @default.
- W2965854857 hasConcept C61511704 @default.
- W2965854857 hasConcept C71924100 @default.
- W2965854857 hasConcept C9893847 @default.
- W2965854857 hasConceptScore W2965854857C105795698 @default.
- W2965854857 hasConceptScore W2965854857C126322002 @default.
- W2965854857 hasConceptScore W2965854857C147483822 @default.
- W2965854857 hasConceptScore W2965854857C159047783 @default.
- W2965854857 hasConceptScore W2965854857C160798450 @default.
- W2965854857 hasConceptScore W2965854857C179223381 @default.
- W2965854857 hasConceptScore W2965854857C203014093 @default.
- W2965854857 hasConceptScore W2965854857C2524010 @default.
- W2965854857 hasConceptScore W2965854857C33923547 @default.
- W2965854857 hasConceptScore W2965854857C61511704 @default.
- W2965854857 hasConceptScore W2965854857C71924100 @default.
- W2965854857 hasConceptScore W2965854857C9893847 @default.
- W2965854857 hasFunder F4320306137 @default.
- W2965854857 hasIssue "7" @default.
- W2965854857 hasLocation W29658548571 @default.
- W2965854857 hasLocation W29658548572 @default.
- W2965854857 hasLocation W29658548573 @default.
- W2965854857 hasLocation W29658548574 @default.
- W2965854857 hasLocation W29658548575 @default.
- W2965854857 hasLocation W29658548576 @default.
- W2965854857 hasLocation W29658548577 @default.
- W2965854857 hasLocation W29658548578 @default.
- W2965854857 hasOpenAccess W2965854857 @default.
- W2965854857 hasPrimaryLocation W29658548571 @default.